2018 American Transplant Congress
Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI.
Purpose: To compare and evaluate 5-year outcomes of graft function for younger (Y) versus elderly (E) kidney transplant recipients (KTR).Introduction: As the number of elderly…2018 American Transplant Congress
Is Kidney Transplantation Safe in Patients over 71 Years Old?
Department of Kidney & Liver Transplantation, ASUIUD, Udine, Italy.
Introduction: Kidney transplantation in elderly patients is superior over dialysis as therapy for end stage renal disease (ESRD). We analyzed different parameters to evaluate patient…2018 American Transplant Congress
Thirty-Six Consecutive Kidney Transplants in Recipients with Atypical Hemolytic Uremic Syndrome: A Single-Centre Experience
Background. Due to high recurrence rate, poor kidney transplant (KTx) survival has been reported for recipients with atypical hemolytic uremic syndrome (aHUS). More recently, prophylaxis…2018 American Transplant Congress
Inflammation in Fibrotic Areas (i-IF/TA) Identifies a T Cell-Mediated Rejection Component of IF/TA with Poor Kidney Allograft Outcome
Paris Translational Research Center for Organ Transplantation, Paris, France.
Addressing the etiological heterogeneity of interstitial fibrosis in kidney allografts represents an important challenge to improve long-term transplant outcomes. We investigated the determinants, clinical and…2018 American Transplant Congress
Optimizing Outcomes with a Collaborative Approach after Kidney Transplant in Hepatitis C-Positive Recipients Receiving Hepatitis C-Positive Grafts
Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, GA.
PURPOSE: To evaluate the multidisciplinary approach to HCV treatment in HCV+ kidney recipients receiving HCV+ grafts. METHODS: Single center review of treatment and outcomes in…2018 American Transplant Congress
Defining Response to Standard of Care Treatment in Kidney Recipients with Antibody-Mediated Rejection: Role of C1q-Binding Donor-Specific Anti-HLA Antibodies
Paris Translational Research Center for Organ Transplantation, Paris, France.
A major hurdle to improving clinical care in kidney transplantation is the lack of biomarkers of the response to antibody-mediated rejection (ABMR) treatment. We investigated…2018 American Transplant Congress
The Utility and Futility of Extra-Corporeal Membrane Oxygenation in Liver Transplant Recipients
University of Southern California, Los Angeles, CA.
Extra-corporeal membrane oxygenation (ECMO) is a therapeutic modality used to treat refractory hypoxemia, and help support cardiogenic shock. These conditions are seen in liver transplant…2018 American Transplant Congress
The Fate of Older Candidates Referred for Kidney Transplantation
Vanderbilt University Medical Center, Nashville, TN.
Background: Older ESRD/CKD patients have reduced access to transplantation compared to younger counterparts as measured by waitlisting and transplantation rates. This is true even in…2018 American Transplant Congress
Inter-Correlations between Psycho-Social Pre-Transplant Determinants of Post-Transplant Kidney Allograft Function
Transplant Services, UTMB, Galveston, TX.
Psycho-social factors are common in patients with advanced and end stage kidney disease and they may be associated with post kidney transplant outcomes. The aim…2018 American Transplant Congress
Does the End Justify the Means? An Analysis of Outcomes in Recipients of Combined Kidney/Hematopoietic Stem Cell (HSC) Transplants and Comparison to Standard of Care (SOC) Patients
1Northwestern U, Chicago; 2U Louisville, Louisville.
Eliminating the long term costs and side effects of immunosuppression (IS) is a compelling reason to pursue transplant tolerance. Tolerance in kidney transplant (KTx) pts…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 155
- Next Page »